Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Friedemann

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Open Forum Infectious Diseases|September 15, 2020
The Course of Mild and Moderate COVID-19 Infections-The Unexpected Long-Lasting ChallengeLu Xia, Jun Chen, Thomas Friedemann, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 7, 2020
Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic studyLu Xia, Yujing Shi, Jie Su, et al.
Frontiers in Pharmacology|June 12, 2024
Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trialChun-Li Lu, Liu-Qing Yang, Xin-Yan Jin, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Open Forum Infectious Diseases|September 15, 2020
The Course of Mild and Moderate COVID-19 Infections-The Unexpected Long-Lasting ChallengeLu Xia, Jun Chen, Thomas Friedemann, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 7, 2020
Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic studyLu Xia, Yujing Shi, Jie Su, et al.
Frontiers in Pharmacology|June 12, 2024
Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trialChun-Li Lu, Liu-Qing Yang, Xin-Yan Jin, et al.
Pageof 3